RADiCAIT
PrivateLast Round
Pre Seed
Oct 16, 2025
Total Funding Raised
$1.82M
Company Overview
RADiCAIT operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Pre Seed round in October 2025.
RADiCAIT is a medical technology company that utilizes foundational artificial intelligence to generate synthetic PET images from CT scans, aiming to improve the accessibility and efficiency of diagnostic imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RADiCAIT Comparables
Compare RADiCAIT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MRIguidance | 67% | |
| Darmiyan | 66% | |
| Cercare Medical | 66% |
For institutional investors. Book with your work email.
RADiCAIT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 16, 2025 | ||||
| Accelerator | Dec 4, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RADiCAIT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Pre Seed, Accelerator |
| Frontline Ventures | Pre Seed |
| Gurtin Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 24, 2025
Grew 400% QoQ from 1 to 5 employees.
- Oct 27, 2025
Pilot study with UCSF Health for lung cancer diagnostics.
For institutional investors. Book with your work email.
RADiCAIT Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RADiCAIT's valuation, stock price, and market status.
Is RADiCAIT a public or private company?
RADiCAIT is a private company.
What is the current stock price of RADiCAIT?
RADiCAIT is a private company, so its shares have no public market price. Caplight tracks RADiCAIT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RADiCAIT worth (valuation)?
Valuation information for RADiCAIT is not publicly available.
Can I buy RADiCAIT stock?
RADiCAIT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RADiCAIT's last funding round?
RADiCAIT's most recent funding round was Pre Seed on October 16, 2025.
Who are the main investors in RADiCAIT?
Key investors in RADiCAIT include Techstars, Frontline Ventures.
Will RADiCAIT IPO soon?
No public IPO plans have been announced for RADiCAIT.
How can I track RADiCAIT secondary market activity?
Caplight tracks bids, offers, and trades in RADiCAIT's shares on secondary markets.